Initiator Pharma A/S (INIT.ST) Stock Price
Initiator Pharma A/S Price
Initiator Pharma A/S stock price
Access this data via the Eulerpool API
100,000 free requests/mo · no credit card
Initiator Pharma A/S business model & stock analysis
Frequently asked questions about Initiator Pharma A/S
Converted at the current exchange rate, the Initiator Pharma A/S share trades at 0.19 EUR (1.41 DKK).
The expected revenue of Initiator Pharma A/S is 53.97 M DKK. This figure is based on current financial data and reflects the company's business performance.
The expected profit of Initiator Pharma A/S is -41.52 M DKK. The net profit reflects the company's profitability after deducting all expenses.
The price-to-earnings ratio (P/E) of Initiator Pharma A/S is currently -2.33. The P/E ratio compares the current share price to the earnings per share and helps investors assess the valuation of the Initiator Pharma A/S stock.
The price-to-sales ratio (P/S) of Initiator Pharma A/S is currently 1.79. The P/S ratio compares the market capitalization to the annual revenue and serves as a valuation metric for the Initiator Pharma A/S stock.
The Eulerpool Quality Score for Initiator Pharma A/S is 2/10.
The ISIN of Initiator Pharma A/S is DK0060775872. The ISIN (International Securities Identification Number) is a globally unique identifier for securities.
The ticker of Initiator Pharma A/S is INIT.ST. The ticker symbol is used to trade Initiator Pharma A/S shares on the stock exchange.
Initiator Pharma A/S stock
Initiator Pharma A/S Peer Group
Initiator Pharma A/S FIGI
All fundamentals and in-depth analysis of Initiator Pharma A/S
Our stock analysis for Initiator Pharma A/S stock includes important financial indicators such as revenue, profit, P/E ratio, P/S ratio, EBIT, as well as information on dividends. We also assess aspects such as stocks, market capitalization, debt, equity, and liabilities of Initiator Pharma A/S. If you are looking for more detailed information on these topics, we offer comprehensive analyses on our subpages.